Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-04-29

FDA Approved: BALCOLTRA — Supplemental Application (Avion Pharmaceuticals)

View source ↗

Summary

FDA approved a supplemental application for BALCOLTRA (levonorgestrel and ethinyl estradiol) submitted by Avion Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BALCOLTRA (Levonorgestrel and Ethinyl Estradiol)

Snippet

SUPPL AP for BALCOLTRA (LEVONORGESTREL AND ETHINYL ESTRADIOL)